Inventor · disambiguated record
Guoqiang Wang
Also filed as: WANG GUOQIANG · WANG GUOQIANG G Q
170 granted patents·49 pending applications·1,461 citations·filing 2001–2025
99Inventor score
Files withENANTA PHARM INC114BOE TECHNOLOGY GROUP CO LTD27FUTUREWEI TECHNOLOGIES INC12OR YAT SUN7WANG GUOQIANG7
Top patents by PatentIndex Score
219 records- 0198US11560368B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2021·Granted Jan 24, 2023·6 cites·18 claims
- 0298US11384090B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jul 12, 2022·14 cites·15 claims
- 0398US11352363B1Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted Jun 7, 2022·13 cites·9 claims
- 0498US11339170B1Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 24, 2022·17 cites·18 claims
- 0598US11325916B1Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 10, 2022·16 cites·15 claims
- 0698US11319325B1Macrocyclic spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2021·Granted May 3, 2022·14 cites·24 claims
- 0798US10683279B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Jun 16, 2020·13 cites·18 claims
- 0898US8667172B2Method and apparatus for content identifier based radius constrained cache flooding to enable efficient content routingRAVINDRAN RAVISHANKAR·Filed 2011·Granted Mar 4, 2014·172 cites·20 claims
- 0998US8575119B22′-chloroacetylenyl substituted nucleoside derivativesWANG GUOQIANG·Filed 2012·Granted Nov 5, 2013·75 cites·22 claims
- 1097US11858945B2Alkyne-containing antiviral agentsENANTA PHARM INC·Filed 2022·Granted Jan 2, 2024·7 cites·16 claims
- 1197US11420976B2Heterocyclic compounds as anti-viral agentsENANTA PHARM INC·Filed 2021·Granted Aug 23, 2022·7 cites·23 claims
- 1297US10988458B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2020·Granted Apr 27, 2021·7 cites·23 claims
- 1397US9137152B2Method for scalable routing in content-oriented networksFUTUREWEI TECHNOLOGIES INC·Filed 2013·Granted Sep 15, 2015·79 cites·19 claims
- 1497US9085599B22′allene-substituted nucleoside derivativesOR YAT SUN·Filed 2012·Granted Jul 21, 2015·45 cites·21 claims
- 1597US7273853B26-11 bicyclic ketolide derivativesENANTA PHARM INC·Filed 2005·Granted Sep 25, 2007·35 cites·29 claims
- 1696US11919910B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Mar 5, 2024·5 cites·13 claims
- 1796US11912714B2Spiropyrrolidine derived antiviral agentsENANTA PHARM INC·Filed 2022·Granted Feb 27, 2024·6 cites·13 claims
- 1896US7189704B26-11 bicyclic ketolide derivativesENANTA PHARM INC·Filed 2005·Granted Mar 13, 2007·15 cites·22 claims
- 1995US10968249B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2020·Granted Apr 6, 2021·3 cites·12 claims
- 2095US10683289B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2019·Granted Jun 16, 2020·10 cites·19 claims
- 2195US10676500B2Process for preparation of sulfonyl carbamate bile acid derivativesENANTA PHARM INC·Filed 2018·Granted Jun 9, 2020·7 cites·8 claims
- 2295US10584145B2Process for preparation of sulfonylurea bile acid derivativesENANTA PHARM INC·Filed 2017·Granted Mar 10, 2020·8 cites·14 claims
- 2395US10450301B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Oct 22, 2019·11 cites·20 claims
- 2495US10246439B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Apr 2, 2019·12 cites·20 claims
- 2594US12018017B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2022·Granted Jun 25, 2024·1 cites·14 claims
- 2694US11834436B2Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2021·Granted Dec 5, 2023·2 cites·5 claims
- 2794US10450306B2Isoxazole analogs as FXR agonists and methods of use thereofENANTA PHARM INC·Filed 2017·Granted Oct 22, 2019·7 cites·22 claims
- 2894US10253018B2Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Apr 9, 2019·10 cites·26 claims
- 2994US10140875B1Method and apparatus for joint optimization of multi-UAV task assignment and path planningUNIV HEFEI TECHNOLOGY·Filed 2018·Granted Nov 27, 2018·138 cites·10 claims
- 3094US10034893B25, 6-D2 uridine nucleoside/tide derivativesENANTA PHARM INC·Filed 2014·Granted Jul 31, 2018·34 cites·19 claims
- 3194US9335977B2Optimization of a data flow program based on access pattern informationNAT INSTR CORP·Filed 2013·Granted May 10, 2016·28 cites·31 claims
- 3294US8846638B2Macrocyclic nucleoside phosphoramidate derivativesENANTA PHARM INC·Filed 2013·Granted Sep 30, 2014·34 cites·22 claims
- 3393US10696713B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Jun 30, 2020·3 cites·15 claims
- 3493US8863227B2Method and apparatus to create and manage a differentiated security framework for content oriented networksZHANG XINWEN·Filed 2011·Granted Oct 14, 2014·20 cites·17 claims
- 3593US6878691B26-11 bicyclic ketolide derivativesENANTA PHARM INC·Filed 2003·Granted Apr 12, 2005·73 cites·26 claims
- 3692US10208081B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2015·Granted Feb 19, 2019·9 cites·53 claims
- 3792US8178531B2Antiviral agentsOR YAT SUN·Filed 2011·Granted May 15, 2012·10 cites·6 claims
- 3892US7135573B2Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamineENANTA PHARM INC·Filed 2005·Granted Nov 14, 2006·18 cites·5 claims
- 3992US6764998B16,11-4C-bicyclic 9a-azalide derivativesENANTA PHARM INC·Filed 2003·Granted Jul 20, 2004·39 cites·19 claims
- 4091US10457703B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2016·Granted Oct 29, 2019·8 cites·16 claims
- 4191US9252942B2Method and system for secure multiparty cloud computationZHANG XINWEN·Filed 2012·Granted Feb 2, 2016·26 cites·12 claims
- 4291US8887121B2Developing programs for hardware implementation in a graphical specification and constraint languageRAVINDRAN KAUSHIK·Filed 2011·Granted Nov 11, 2014·18 cites·27 claims
- 4391US8648037B2Macrocyclic proline derived HCV serine protease inhibitorsOR YAT SUN·Filed 2011·Granted Feb 11, 2014·12 cites·255 claims
- 4491US8367618B2Cyclosporin analogues for preventing or treating hepatitis C infectionENANTA PHARM INC·Filed 2010·Granted Feb 5, 2013·6 cites·13 claims
- 4590US10597382B2Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereofENANTA PHARM INC·Filed 2018·Granted Mar 24, 2020·10 cites·17 claims
- 4690US8719774B2Developing programs for hardware implementation in a graphical specification and constraint language Via iterative estimation of performance or resource utilizationWANG GUOQIANG·Filed 2011·Granted May 6, 2014·12 cites·18 claims
- 4789US11718641B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2021·Granted Aug 8, 2023·1 cites·5 claims
- 4889US11040998B2Bile acid derivatives as FXR/TGR5 agonists and methods of use thereofENANTA PHARM INC·Filed 2019·Granted Jun 22, 2021·2 cites·17 claims
- 4989US7402568B2Bicyclic 9a-azalide derivativesENANTA PHARM INC·Filed 2005·Granted Jul 22, 2008·16 cites·22 claims
- 5089US7384922B26-11 bridged oxime erythromycin derivativesENANTA PHARM INC·Filed 2006·Granted Jun 10, 2008·14 cites·11 claims
Showing the top 50 of 219 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Guoqiang Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →